Funder
National Human Genome Research Institute
U.S. Food and Drug Administration
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference28 articles.
1. Lips EH, Mulder L, de Ronde JJ, IAM M, Koolen BB, LFA W, et al. Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response. Breast Cancer Res Treat Springer US. 2013;140:63–71.
2. Won JR, Gao D, Chow C, Cheng J, Lau SYH, Ellis MJ, et al. A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standard. Mod Pathol. 2013;26:1438–50.
3. Abu-Khalf M, Pusztai L. Influence of genomics on adjuvant treatments for pre-invasive and invasive breast cancer. Breast. 2013;22(Suppl 2):S83–7.
4. Cardenas Sanchez J, Rocha JEB, Piña VB, Sánchez GC, Erazo Valle-Solís AA, Balcázar CHF, et al. Mexican Consensus on the Diagnosis and Treatment of Breast Cancer: Seventh Revision - Colima 2017. Gaceta Mexicana de Oncología. 2017;16:7–78.
5. Secretaria de Salud de Mexico. Diagnóstico y Tratamiento de la Patología Mamaria Benigna en Primer y Segundo Nivel de Atención; 2009. p. 1–66.